Tenon Medical Financials
TNON Stock | USD 1.18 0.04 3.51% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 0.93 | 1.11 |
|
|
The essential information of the day-to-day investment outlook for Tenon Medical includes many different criteria found on its balance sheet. An individual investor should monitor Tenon Medical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Tenon Medical.
Net Income |
|
Tenon | Select Account or Indicator |
Tenon Medical Stock Summary
Tenon Medical competes with Ainos, STRATA Skin, Neuropace, Movano, and Tivic Health. Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixationfusion surgery and corresponding outcomes. The company was founded in 2012 and is based in Los Gatos, California. Tenon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 8 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US88066N1054 |
CUSIP | 88066N105 88066N204 88066N303 |
Location | California; U.S.A |
Business Address | 104 Cooper Court, |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.tenonmed.com |
Phone | 408 649 5760 |
Currency | USD - US Dollar |
Tenon Medical Key Financial Ratios
Return On Equity | -2.56 | ||||
Operating Margin | (3.62) % | ||||
Price To Sales | 1.08 X | ||||
Revenue | 2.93 M | ||||
Gross Profit | 1.92 M |
Tenon Medical Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 390.9K | 9.3M | 11.1M | 6.3M | 7.3M | 6.0M | |
Other Current Liab | 663.7K | 1.1M | 1.5M | 1.3M | 1.5M | 1.1M | |
Net Debt | 329.3K | 11.7M | (1.2M) | (571K) | (513.9K) | (488.2K) | |
Retained Earnings | (4.5M) | (20.6M) | (39.5M) | (55.1M) | (49.6M) | (47.1M) | |
Accounts Payable | 589.2K | 478K | 550K | 433K | 389.7K | 399.6K | |
Cash | 245.6K | 2.9M | 2.1M | 2.4M | 2.8M | 1.7M | |
Net Receivables | 14.5K | 93.6K | 228K | 518K | 595.7K | 625.5K | |
Inventory | 43.3K | 188.4K | 415K | 554K | 637.1K | 669.0K | |
Other Current Assets | 0.0 | 69.2K | 134K | 389K | 447.4K | 469.7K | |
Total Liab | 3.1M | 29.8M | 4.8M | 5.6M | 6.4M | 9.9M | |
Total Current Assets | 303.4K | 7.7M | 9.3M | 3.9M | 4.5M | 4.7M | |
Short Term Debt | 241.4K | 13.7M | 456K | 1.4M | 1.6M | 1.6M | |
Common Stock | 830.0 | 990.0 | 11K | 3K | 3.5K | 3.8K |
Tenon Medical Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 167.8K | 620.8K | 354K | 21K | 24.2K | 22.9K | |
Total Revenue | 43.8K | 159.8K | 691K | 2.9M | 3.4M | 3.5M | |
Gross Profit | 25.6K | 105.0K | (641K) | 1.2M | 1.4M | 1.5M | |
Operating Income | (536.3K) | (6.5M) | (18.7M) | (15.7M) | (14.2M) | (13.4M) | |
Ebit | (1.1M) | (6.5M) | (18.6M) | (15.7M) | (14.2M) | (13.4M) | |
Research Development | 220.9K | 1.7M | 2.8M | 3.2M | 3.6M | 1.8M | |
Ebitda | (537.5K) | (6.3M) | (18.3M) | (15.5M) | (14.0M) | (13.3M) | |
Income Before Tax | (705.4K) | (7.1M) | (18.9M) | (15.6M) | (14.0M) | (13.3M) | |
Net Income | (753.0K) | (7.7M) | (19.1M) | (15.6M) | (14.0M) | (13.3M) |
Tenon Medical Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change To Inventory | 18.3K | (145.1K) | (227K) | (139K) | (125.1K) | (131.4K) | |
Change In Cash | 93.7K | 2.7M | (788K) | 299K | 269.1K | 388.4K | |
Free Cash Flow | (167.4K) | (4.4M) | (12.9M) | (12.5M) | (11.3M) | (10.7M) | |
Other Non Cash Items | 167.8K | 1.8M | 2.0M | 1.0 | 1.15 | 1.09 | |
Net Income | (705.4K) | (7.1M) | (18.9M) | (15.6M) | (14.0M) | (13.3M) | |
End Period Cash Flow | 245.6K | 2.9M | 2.1M | 2.4M | 2.8M | 1.7M |
Tenon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tenon Medical's current stock value. Our valuation model uses many indicators to compare Tenon Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tenon Medical competition to find correlations between indicators driving Tenon Medical's intrinsic value. More Info.Tenon Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Tenon Medical's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tenon Medical's earnings, one of the primary drivers of an investment's value.Tenon Medical Systematic Risk
Tenon Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tenon Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Tenon Medical correlated with the market. If Beta is less than 0 Tenon Medical generally moves in the opposite direction as compared to the market. If Tenon Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tenon Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tenon Medical is generally in the same direction as the market. If Beta > 1 Tenon Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Tenon Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tenon Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tenon Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Tenon Medical March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tenon Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tenon Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tenon Medical based on widely used predictive technical indicators. In general, we focus on analyzing Tenon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tenon Medical's daily price indicators and compare them against related drivers.
Information Ratio | (0.11) | |||
Maximum Drawdown | 47.29 | |||
Value At Risk | (6.31) | |||
Potential Upside | 8.4 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Tenon Stock, please use our How to Invest in Tenon Medical guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenon Medical. If investors know Tenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 287.92 | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets | Return On Equity |
The market value of Tenon Medical is measured differently than its book value, which is the value of Tenon that is recorded on the company's balance sheet. Investors also form their own opinion of Tenon Medical's value that differs from its market value or its book value, called intrinsic value, which is Tenon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenon Medical's market value can be influenced by many factors that don't directly affect Tenon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.